KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Recursion Pharmaceuticals (RXRX) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Recursion Pharmaceuticals (RXRX) over the last 5 years, with Q3 2025 value amounting to 0.03.

  • Recursion Pharmaceuticals' Asset Utilization Ratio fell 6273.18% to 0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03, marking a year-over-year decrease of 6273.18%. This contributed to the annual value of 0.06 for FY2024, which is 1492.24% down from last year.
  • Latest data reveals that Recursion Pharmaceuticals reported Asset Utilization Ratio of 0.03 as of Q3 2025, which was down 6273.18% from 0.05 recorded in Q2 2025.
  • Recursion Pharmaceuticals' Asset Utilization Ratio's 5-year high stood at 0.09 during Q3 2024, with a 5-year trough of 0.02 in Q3 2021.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.05 (2025), whereas its average is 0.05.
  • Per our database at Business Quant, Recursion Pharmaceuticals' Asset Utilization Ratio surged by 27838.07% in 2022 and then crashed by 6273.18% in 2025.
  • Quarter analysis of 5 years shows Recursion Pharmaceuticals' Asset Utilization Ratio stood at 0.02 in 2021, then surged by 278.38% to 0.06 in 2022, then rose by 14.34% to 0.07 in 2023, then decreased by 22.05% to 0.05 in 2024, then tumbled by 40.23% to 0.03 in 2025.
  • Its Asset Utilization Ratio stands at 0.03 for Q3 2025, versus 0.05 for Q2 2025 and 0.04 for Q1 2025.